Streetwise Medical Devices Articles


Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device

Research Report
  ()
A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. read more >

Medical Device Firm's Clinical Programs Progress in Q2/18

Research Report
  ()
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. read more >

Medical Device Firm Anticipates Benefit from Patent Ruling

  ()
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. read more >

Interim Readout for Pharma Trial 'Delivers Home Run'

Research Report
  ()
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. read more >

Agreement Facilitates Progress Toward Medical Device Approvals

  ()
This medical device company enters a partnership to provide quality and regulatory services. read more >

Coverage Initiated on Developer of Women's Reproductive Health Products

Research Report
  ()
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. read more >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'

Research Report
  ()
Cowen analyst Dr. Joshua Jennings highlighted this medical device firmís Q1/18 developments and financial results. read more >

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease

  ()
In the second of a two-part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small-cap companies targeting big-ticket indications and their potential to drive blockbuster value for both patients and investors. read more >

Medical Device Firm Posts 'Strong Performance' Globally in Q4/17

Research Report
  ()
The company performed strongly in the U.S. and the Asia Pacific region. read more >

Convergence Will Drive the Ultimate Disruption of Life Sciences

Contributed Opinion
  ()
Andrea Bartzen, a strategic commercial and communication consultant, describes the disruptive technologies positioned to radically alter the business of life sciences as discussed at a recent BIO CEO Summit Investor Night. read more >
Showing Results: 1 to 10 of 10

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts